642 related articles for article (PubMed ID: 20522426)
1. Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech.
Bonnet C; Andrieux J; Béri-Dexheimer M; Leheup B; Boute O; Manouvrier S; Delobel B; Copin H; Receveur A; Mathieu M; Thiriez G; Le Caignec C; David A; de Blois MC; Malan V; Philippe A; Cormier-Daire V; Colleaux L; Flori E; Dollfus H; Pelletier V; Thauvin-Robinet C; Masurel-Paulet A; Faivre L; Tardieu M; Bahi-Buisson N; Callier P; Mugneret F; Edery P; Jonveaux P; Sanlaville D
J Med Genet; 2010 Jun; 47(6):377-84. PubMed ID: 20522426
[TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1.
Rajcan-Separovic E; Harvard C; Liu X; McGillivray B; Hall JG; Qiao Y; Hurlburt J; Hildebrand J; Mickelson EC; Holden JJ; Lewis ME
J Med Genet; 2007 Apr; 44(4):269-76. PubMed ID: 16963482
[TBL] [Abstract][Full Text] [Related]
3. Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes.
Bruno DL; Anderlid BM; Lindstrand A; van Ravenswaaij-Arts C; Ganesamoorthy D; Lundin J; Martin CL; Douglas J; Nowak C; Adam MP; Kooy RF; Van der Aa N; Reyniers E; Vandeweyer G; Stolte-Dijkstra I; Dijkhuizen T; Yeung A; Delatycki M; Borgström B; Thelin L; Cardoso C; van Bon B; Pfundt R; de Vries BB; Wallin A; Amor DJ; James PA; Slater HR; Schoumans J
J Med Genet; 2010 May; 47(5):299-311. PubMed ID: 20452996
[TBL] [Abstract][Full Text] [Related]
4. A de novo microtriplication at 4q21.21-q21.22 in a patient with a vascular malignant hemangioma, elongated sigmoid colon, developmental delay, and absence of speech.
Lebedev IN; Nazarenko LP; Skryabin NA; Babushkina NP; Kashevarova AA
Am J Med Genet A; 2016 Aug; 170(8):2089-96. PubMed ID: 27288323
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation.
Koolen DA; Reardon W; Rosser EM; Lacombe D; Hurst JA; Law CJ; Bongers EM; van Ravenswaaij-Arts CM; Leisink MA; van Kessel AG; Veltman JA; de Vries BB
Eur J Hum Genet; 2005 Sep; 13(9):1019-24. PubMed ID: 15986041
[TBL] [Abstract][Full Text] [Related]
6. Further defining the critical genes for the 4q21 microdeletion disorder.
Hu X; Chen X; Wu B; Soler IM; Chen S; Shen Y
Am J Med Genet A; 2017 Jan; 173(1):120-125. PubMed ID: 27604828
[TBL] [Abstract][Full Text] [Related]
7. 2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features?
Jaillard S; Dubourg C; Gérard-Blanluet M; Delahaye A; Pasquier L; Dupont C; Henry C; Tabet AC; Lucas J; Aboura A; David V; Benzacken B; Odent S; Pipiras E
J Med Genet; 2009 Dec; 46(12):847-55. PubMed ID: 18812405
[TBL] [Abstract][Full Text] [Related]
8. 19q13.11 deletion syndrome: a novel clinically recognisable genetic condition identified by array comparative genomic hybridisation.
Malan V; Raoul O; Firth HV; Royer G; Turleau C; Bernheim A; Willatt L; Munnich A; Vekemans M; Lyonnet S; Cormier-Daire V; Colleaux L
J Med Genet; 2009 Sep; 46(9):635-40. PubMed ID: 19126570
[TBL] [Abstract][Full Text] [Related]
9. Interstitial 9q22.3 microdeletion: clinical and molecular characterisation of a newly recognised overgrowth syndrome.
Redon R; Baujat G; Sanlaville D; Le Merrer M; Vekemans M; Munnich A; Carter NP; Cormier-Daire V; Colleaux L
Eur J Hum Genet; 2006 Jun; 14(6):759-67. PubMed ID: 16570072
[TBL] [Abstract][Full Text] [Related]
10. Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation.
Battaglia A; Hoyme HE; Dallapiccola B; Zackai E; Hudgins L; McDonald-McGinn D; Bahi-Buisson N; Romano C; Williams CA; Brailey LL; Zuberi SM; Carey JC
Pediatrics; 2008 Feb; 121(2):404-10. PubMed ID: 18245432
[TBL] [Abstract][Full Text] [Related]
11. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome).
Sarasua SM; Dwivedi A; Boccuto L; Rollins JD; Chen CF; Rogers RC; Phelan K; DuPont BR; Collins JS
J Med Genet; 2011 Nov; 48(11):761-6. PubMed ID: 21984749
[TBL] [Abstract][Full Text] [Related]
12. DNA microarray analysis identifies candidate regions and genes in unexplained mental retardation.
Engels H; Brockschmidt A; Hoischen A; Landwehr C; Bosse K; Walldorf C; Toedt G; Radlwimmer B; Propping P; Lichter P; Weber RG
Neurology; 2007 Mar; 68(10):743-50. PubMed ID: 17339581
[TBL] [Abstract][Full Text] [Related]
13. Expanding the spectrum of microdeletion 4q21 syndrome: a partial phenotype with incomplete deletion of the minimal critical region and a new association with cleft palate and Pierre Robin sequence.
Bhoj E; Halbach S; McDonald-McGinn D; Tan C; Lande R; Waggoner D; Zackai E
Am J Med Genet A; 2013 Sep; 161A(9):2327-33. PubMed ID: 23913759
[TBL] [Abstract][Full Text] [Related]
14. Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome.
Van der Aa N; Rooms L; Vandeweyer G; van den Ende J; Reyniers E; Fichera M; Romano C; Delle Chiaie B; Mortier G; Menten B; Destrée A; Maystadt I; Männik K; Kurg A; Reimand T; McMullan D; Oley C; Brueton L; Bongers EM; van Bon BW; Pfund R; Jacquemont S; Ferrarini A; Martinet D; Schrander-Stumpel C; Stegmann AP; Frints SG; de Vries BB; Ceulemans B; Kooy RF
Eur J Med Genet; 2009; 52(2-3):94-100. PubMed ID: 19249392
[TBL] [Abstract][Full Text] [Related]
15. New cases and refinement of the critical region in the 1q41q42 microdeletion syndrome.
Rosenfeld JA; Lacassie Y; El-Khechen D; Escobar LF; Reggin J; Heuer C; Chen E; Jenkins LS; Collins AT; Zinner S; Babcock M; Morrow B; Schultz RA; Torchia BS; Ballif BC; Tsuchiya KD; Shaffer LG
Eur J Med Genet; 2011; 54(1):42-9. PubMed ID: 20951845
[TBL] [Abstract][Full Text] [Related]
16. Microdeletions including YWHAE in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment.
Nagamani SC; Zhang F; Shchelochkov OA; Bi W; Ou Z; Scaglia F; Probst FJ; Shinawi M; Eng C; Hunter JV; Sparagana S; Lagoe E; Fong CT; Pearson M; Doco-Fenzy M; Landais E; Mozelle M; Chinault AC; Patel A; Bacino CA; Sahoo T; Kang SH; Cheung SW; Lupski JR; Stankiewicz P
J Med Genet; 2009 Dec; 46(12):825-33. PubMed ID: 19584063
[TBL] [Abstract][Full Text] [Related]
17. The del(2)(q32.2q33) deletion syndrome defined by clinical and molecular characterization of four patients.
Van Buggenhout G; Van Ravenswaaij-Arts C; Mc Maas N; Thoelen R; Vogels A; Smeets D; Salden I; Matthijs G; Fryns JP; Vermeesch JR
Eur J Med Genet; 2005; 48(3):276-89. PubMed ID: 16179223
[TBL] [Abstract][Full Text] [Related]
18. De novo deletion of chromosome 2q24.2 region in a mentally retarded boy with muscular hypotonia.
Magri C; Piovani G; Pilotta A; Michele T; Buzi F; Barlati S
Eur J Med Genet; 2011; 54(3):361-4. PubMed ID: 21211576
[TBL] [Abstract][Full Text] [Related]
19. Further delineation of novel 1p36 rearrangements by array-CGH analysis: narrowing the breakpoints and clarifying the "extended" phenotype.
Giannikou K; Fryssira H; Oikonomakis V; Syrmou A; Kosma K; Tzetis M; Kitsiou-Tzeli S; Kanavakis E
Gene; 2012 Sep; 506(2):360-8. PubMed ID: 22766398
[TBL] [Abstract][Full Text] [Related]
20. Case series: 2q33.1 microdeletion syndrome--further delineation of the phenotype.
Balasubramanian M; Smith K; Basel-Vanagaite L; Feingold MF; Brock P; Gowans GC; Vasudevan PC; Cresswell L; Taylor EJ; Harris CJ; Friedman N; Moran R; Feret H; Zackai EH; Theisen A; Rosenfeld JA; Parker MJ
J Med Genet; 2011 May; 48(5):290-8. PubMed ID: 21343628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
